DONATE TODAY
To Increase Patient Access

PDUFA

The Prescription Drug User Fee Act
TAKE ACTION BY SIGNING TODAY!
As we near a September deadline for Congress to renew crucial FDA funds that support patients across the world, the EndBrainCancer Initiative (EBCI) and I urge swift passage of PDUFA reauthorization (re-funding). PDUFA leads to quicker patient access to drugs/treatment options. Join EBCI and #ScienceWorks to move this VITAL legislation forward as we don’t want any patient/family to have to WAIT FOR A CURE!

The prescription drug act (PDUFA) reduced drug application review times, which lead to new drugs for patients, by the FDA by half and shaved an average two years off the wait time for “priority medicines.” Rapid deployment of today’s effective and innovative COVID-19 vaccines is proof that this policy infrastructure is still vital in maintaining our health and well-being.
OUR LEGISLATURES/COMMITTEES ARE VOTING ON THIS VITAL PIECE OF LEGISLATION ON OR BEFORE SEPT. 29TH.
Click the images below for more information.
PLEASE SIGN THE
SUPPORT PETITION BY 9/25
Click the button above  to fill out this short form to let Senator Murray know that you support funding (re-authorization) by our legislatures for PDUFA. Getting YOUR message directly to Senator Murray is VITAL as she leads both the Appropriations Committee and the HELP Committee, responsible for re-authorization of PDUFA.

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.
DONATE
envelopephone linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram